XML 42 R11.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Investments | 12 Months Ended
--- | ---
Aug. 31, 2018
Investments [Abstract] |
Investments | Investments Investments as of August 31, 2018, and 2017, are as follows:
| 2018 |  | 2017
| (Dollars in thousands)
Equity method investments: |  |  |
CF Industries Nitrogen, LLC | $ | 2,735,073 |  |  | $ | 2,756,076 |
Ventura Foods, LLC | 360,150 |  |  | 347,016 |
Ardent Mills, LLC | 205,898 |  |  | 206,529 |
Other equity method investments | 288,016 |  |  | 309,767 |
Cost method and other investments | 122,788 |  |  | 131,605 |
Total investments | $ | 3,711,925 |  |  | $ | 3,750,993 |
Joint ventures and other investments in which we have significant ownership and influence but not control, are accounted for in our consolidated financial statements using the equity method of accounting. Our significant equity method investments consist of CF Nitrogen, Ventura Foods, and Ardent Mills, LLC ("Ardent Mills"), which are summarized below. CF Nitrogen On February 1, 2016, we invested $2.8 billion in CF Nitrogen, commencing our strategic venture with CF Industries Holdings, Inc. The investment consists of an approximate 10% membership interest (based on product tons) in CF Nitrogen. We also entered into an 80-year supply agreement that entitles us to purchase up to 1.1 million tons of granular urea and 580,000 tons of urea ammonium nitrate ("UAN") annually from CF Nitrogen for ratable delivery. Our purchases under the supply agreement are based on prevailing market prices and we receive semi-annual cash distributions (in January and July of each year) from CF Nitrogen via our membership interest. These distributions are based on actual volumes purchased from CF Nitrogen under the strategic venture and will have the effect of reducing our investment to zero over 80 years on a straight-line basis. We account for this investment using the hypothetical liquidation at book value method, recognizing our share of the earnings and losses of CF Nitrogen based upon our contractual claims on the entity's net assets pursuant to the liquidation provisions of CF Nitrogen's Limited Liability Company Agreement, adjusted for the semi-annual cash distributions. For the years ended August 31, 2018, and 2017, these amounts were $106.9 million and $66.5 million, respectively, and are included as equity income from investments in our Nitrogen Production segment. The following tables provide aggregate summarized financial information for CF Nitrogen for the balance sheets as of August 31, 2018, and 2017, and the statements of operations for the twelve months ended August 31, 2018, and 2017, and the seven months ended August 31, 2016:
| 2018 |  | 2017
| (Dollars in thousands)
Current assets | $ | 576,076 |  |  | $ | 394,089 |
Non-current assets | 7,447,594 |  |  | 7,314,629 |
Current liabilities | 215,104 |  |  | 390,206 |
Non-current liabilities | 71 |  |  | 6 |
| 2018 |  | 2017 |  | 2016
| (Dollars in thousands)
Net sales | $ | 2,449,695 |  |  | $ | 2,051,159 |  |  | $ | 1,027,142 |
Gross profit | 423,612 |  |  | 195,142 |  |  | 243,911 |
Net earnings | 401,295 |  |  | 123,965 |  |  | 186,665 |
Earnings attributable to CHS Inc. | 106,895 |  |  | 66,530 |  |  | 74,700 |
Ventura Foods and Ardent Mills We have a 50% interest in Venture Foods which is a joint venture that produces and distributes primarily vegetable oil-based products and we have a 12% interest in Ardent Mills, which is a joint venture with Cargill Incorporated ("Cargill") and ConAgra Foods, Inc., which combines the North American flour milling operations of the three parent companies. We account for Ventura Foods and Ardent Mills as equity method investments included in Corporate and Other. The following tables provide aggregate summarized financial information for our equity method investments in Ventura Foods and Ardent Mills for balance sheets as of August 31, 2018, and 2017, and statements of operations for the twelve months ended August 31, 2018, 2017 and 2016:
| 2018 |  | 2017
| (Dollars in thousands)
Current assets | $ | 1,462,590 |  |  | $ | 1,483,384 |
Non-current assets | 2,331,295 |  |  | 2,358,434 |
Current liabilities | 671,928 |  |  | 685,462 |
Non-current liabilities | 693,360 |  |  | 765,078 |
| 2018 |  | 2017 |  | 2016
| (Dollars in thousands)
Net sales | $ | 5,882,035 |  |  | $ | 5,762,849 |  |  | $ | 5,694,622 |
Gross profit | 601,927 |  |  | 673,329 |  |  | 677,920 |
Net earnings | 226,776 |  |  | 265,126 |  |  | 265,025 |
Earnings attributable to CHS Inc. | 46,069 |  |  | 60,716 |  |  | 88,936 |
Our investments in other equity method investees are not significant in relation to our consolidated financial statements, either individually or in the aggregate.

X
- Definition The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses). + References No definition available. + Details
Name: | us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration